Search database
LIST OPTIONS
Filter
99
Filtered Results: 99
Text search: heterologous
Featured
Language
Document type
Guidelines
39
No document type
32
Studies & Reports
12
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
South Africa
3
Latin America and the Carribbean
3
Africa
3
Nigeria
2
Mozambique
2
Bolivia
2
Paraguay
2
Russia
2
Uganda
1
Philippines
1
Germany
1
Tanzania
1
Indonesia
1
Ecuador
1
Chile
1
East and Southern Africa
1
Asia
1
Global
1
Authors & Publishers
World Health Organization WHO
34
Ministerio de Salud Argentina
4
OPAS
4
World Health Organization
4
Abela-Ridder, B.
2
Dirección de Control de Enfermedades Inmunoprevenibles
2
Federal Ministry of Health, Nigeria
2
Feraud, H.
2
Indian Council of Medical Research
2
Organisation Mondiale de la Santé OMS
2
Organización Mundial de la Salud OMS
2
Organización Mundial de Saude and OPAS
2
Organização Mundial da Saúde (OMS)
2
Rupprecht, C.
2
WHO
2
World Health Organization (WHO)
2
World Heart Federation
2
Abubakar, B.K.
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Ahmad, U., Chau, D.M. et al.
1
Bill & Melinda Gates Foundation
1
BioMed Central
1
BMC Part of Springer Nature
1
BooMed Central
1
Dept. of Health South Africa
1
Dra. María Cristina San Miguel de Vera
1
Elsevier Ltd.
1
Erwinanto, A. Santoso, J. N. E. Putranto, et al.,
1
Fairlamb, A.H.
1
Ference, B.A.
1
Fooks, A,
1
Fooks, A.
1
Garratt, A.
1
Gavi, the Vaccine Alliance
1
Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta
1
Guo, J.
1
HelpAge
1
Hill, A.
1
Hindawi Publishing Corporation
1
Horn, D.
1
IACAPAP
1
Ibarra-Cerdena, C.
1
Indonesian Heart Association
1
Izeta-Alberdi, A.
1
J. A. Triccas, C. Counoupas
1
J. J. C. Nuttal, B. S. Eley
1
Jara A., Undurraga E. A. et al
1
JCI insight
1
Journal of Cystic Fibrosis
1
Journal of Movements Disorders
1
Logunov, D.Y, et al.
1
M. A. Gasper, A. C. Hesseling, I. Mohar, et al.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud
1
Ministerio de Salud Bolivia
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de Salud, Argentina
1
Ministério da Saúde, Brasil
1
Ministry of Health & Family Welfare India
1
Moo-llanes, D.
1
Muntean Al., Popa M.
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health, South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Rabies Programme
1
O. Bandmann
1
OPAS, OMS
1
OPS
1
Organización Panamericana de la Salud
1
Pan American Health Organisation PAHO
1
Pan American Health Organization PAHO
1
Pneumonia
1
Popa G.
1
R. R. Althoff
1
R. Walker
1
Ramsey,J.
1
Ray, K.K.
1
RCC Service
1
Saudi Journal of Biological Sciences
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Séverin, T. et al.
1
TDR
1
Trials
1
U. Williams
1
UNICEF
1
V. Nankabirwa , J. K. Tumwine, O. Namugga, et al.
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organisation (WHO)
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, SAGE
1
World Health Organization, Regional Office for the Americas
1
Publication Years
Category
Countries
34
Clinical Guidelines
10
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
48
NTDs
6
Rapid Response
5
TB
4
NCDs
3
Zika
2
Mental Health
2
Ebola
1
Polio
1
Global Health Education
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp... more
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been ... more
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no... more
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. Th... more
Interim guidance, 26 October 2021 This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021. SAGE said moderately and severely immunocompromised persons should be offered an addition... more
27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Updated Treatment Guidelines
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022 Available in English, F... more
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc... more
Data for Action March 2022, Issue 5
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f... more